Nose Diseases  >>  Veramyst (fluticasone furoate nasal spray)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Veramyst (fluticasone furoate nasal spray) / GSK
NCT01199757: A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures

Completed
N/A
540
NA
Fluticasone furoate, AVAMYS™, mometasone furoate, NASONEX™, fluticasone propionate, FLIXONASE™
GlaxoSmithKline, Adelphi Real World
Rhinitis, Allergic, Perennial
08/09
08/09
NCT01337323: Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting

Terminated
N/A
3
NA
Fluticasone furoate nasal spray, Flonase® is a registered trademark of GlaxoSmithKline
GlaxoSmithKline
Rhinitis, Allergic, Seasonal, Seasonal Allergic Rhinitis
09/11
09/11
NCT01318681 / 2010-021933-30: Rhinitis, Cognition and Driving Performance

Completed
N/A
22
Europe
cetirizine 10 mg, fluticasone furoate, placebo
Maastricht University Medical Center
Seasonal Allergic Rhinitis, Driving Ability, Cognition
03/12
10/12
NCT01001130: Regulatory AVAMYS Nasal Spray PMS

Completed
N/A
3244
RoW
fluticasone furoate group, according to label and physician's decision
GlaxoSmithKline
Rhinitis, Allergic, Perennial and Seasonal
05/14
05/14

Download Options